Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Current Assets (2021 - 2025)

Bioregenx's Current Assets history spans 5 years, with the latest figure at $251265.0 for Q4 2025.

  • Quarterly results put Current Assets at $251265.0 for Q4 2025, down 18.37% from a year ago — trailing twelve months through Dec 2025 was $251265.0 (down 18.37% YoY), and the annual figure for FY2025 was $251265.0, down 18.37%.
  • Current Assets for Q4 2025 was $251265.0 at Bioregenx, down from $273156.0 in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $652664.0 in Q4 2023 to a low of $676.0 in Q4 2022.
  • The 5-year median for Current Assets is $283708.5 (2025), against an average of $269757.2.
  • The sharpest move saw Current Assets tumbled 97.22% in 2022, then skyrocketed 96447.93% in 2023.
  • Year by year, Current Assets stood at $24358.0 in 2021, then tumbled by 97.22% to $676.0 in 2022, then skyrocketed by 96447.93% to $652664.0 in 2023, then plummeted by 52.84% to $307796.0 in 2024, then dropped by 18.37% to $251265.0 in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $251265.0, $273156.0, and $249573.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.